Statera Biopharma drops on stock-and-warrants offering

Statera Biopharma

22/03/2022 10:56

** Shares of Statera Biopharma  STAB.O  fall ~20% to 48
cents premarket
    ** Co launches an offering of units that consist of one
share of common stock and one warrant to purchase one share of
common stock, as well as pre-funded units that consist of one
pre-funded warrant to purchase one share of common stock and one
warrant
    ** Size of the offering was not disclosed  urn:newsml:reuters.com:*:nGNX8b9t29
    ** EF Hutton, a division of Benchmark Investments LLC, is
acting as the sole book-runner for the offering
    ** The immune therapy developer sold ~2 mln shares to an
institutional investor in Feb.  urn:newsml:reuters.com:*:nL4N2UI2TL
    ** STAB down 74% since the start of the year, hovering near
levels last seen in early 2020

 (Reporting by Medha Singh)
 ((medha.singh@thomsonreuters.com))